Recent Updates
Recently added Catalysts
DXCM Positive Sentiment

Dexcom Announces Upcoming March 2026 Conference Presentation

Thursday, February 26, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Dexcom, Inc. has announced that its management will present at the 47th Annual Raymond James Institutional Investors Conference on March 2, 2026. The presentation will begin at approximately 1:05 PM EST and will be available via live webcast. This event underscores Dexcom's ongoing commitment to investor relations and transparency.
Price reaction · baseline $73.16 (2026-02-25 close) · hit pre-market · clean, no other DXCM news in the window
day 0 close · peak
+1.7%

Market Sentiment Analysis

POSITIVE FACTORS

  • Dexcom is actively engaging with investors through presentations.
  • The upcoming conference highlights Dexcom's commitment to transparency.
  • The company has a strong history of innovation in glucose biosensing.

Full Press Release Details

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc.(NASDAQ:DXCM) today announced that management will present an update on the company at the 47thAnnual Raymond James Institutional Investors Conference on Monday, March 2, 2026.
The live presentation is scheduled to begin at approximately 1:05 PM EST and will be concurrently webcast.
Links to the webcast will be available on the Dexcom Investor Relations website atinvestors.dexcom.comand will be archived there for future reference.
About DexCom, Inc.
Dexcom empowers people to take control of health through innovative biosensing technology. Founded in 1999, Dexcom has pioneered and set the standard in glucose biosensing for more than 25 years. Its technology has transformed how people manage diabetes and track their glucose, helping them feel more in control and live more confidently.
Dexcom. Discover what you’re made of. For more information, visitwww.dexcom.com.
Category: IR

Frequently Asked Questions

When is the Dexcom conference presentation scheduled?

The presentation is scheduled for March 2, 2026, at 1:05 PM EST.

Where can I watch the Dexcom presentation?

The presentation will be webcast live and archived on Dexcom's Investor Relations website.

What is the focus of Dexcom's technology?

Dexcom specializes in glucose biosensing technology for diabetes management.

Who can I contact for investor relations at Dexcom?

Sean Christensen is the Vice President of Finance and Investor Relations.

ShareAdd on Google
Tags: DXCM Viatris Investor Conferences Healthcare Dexcom Raymond James investor relations glucose biosensing NASDAQ:DXCM
Last updated: Feb 26, 2026

Biotech snapshot

Cash runway
$2084M liquidity · $0M/mo burn
Low dilution risk
Lead asset
Basal insulinPhase 1
Type 2 Diabetes →